Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies

Blood

Volumn 126, Issue 10, 2015, Pages 1234-1236

  Liu, Zhi Jian ^a   Bussel, James B ^b   Lakkaraja, Madhavi ^b   Ferrer Marin, Francisca ^a,c   Ghevaert, Cedric ^d   Feldman, Henry A ^a   McFarland, Janice G ^e   Chavda, Chaitanya ^a   Sola Visner, Martha ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c HOSPITAL MORALES MESEGUER   (Spain)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 1 ANTIBODY; IMMUNOGLOBULIN; MATERNAL ANTIBODY; PREDNISONE; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG; 1A ALLOANTIGEN, HUMAN;

ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; MATERNAL SERUM; MEGAKARYOBLAST; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT RESPONSE; HEMATOPOIESIS; IMMUNOLOGY; PATHOPHYSIOLOGY; PREGNANCY;

ANTIGENS, HUMAN PLATELET; FEMALE; HEMATOPOIESIS; HUMANS; IN VITRO TECHNIQUES; MEGAKARYOCYTES; PREGNANCY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84942518050     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-611020     Document Type: Article

References (16)

1. Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161(1):3-14.
2. Espinoza JP, Caradeux J, Norwitz ER, Illanes SE. Fetal and neonatal alloimmune thrombocytopenia. Rev Obstet Gynecol. 2013;6(1):e15-e21.
3. Vinograd CA, Bussel JB. Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective. Haematologica. 2010;95(11):1807-1811.
4. Wiener E, Abeyakoon O, Benchetrit G, Lyall M, Keler T, Rodeck CH. Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (FcgammaR) reactive reagents. Eur J Haematol. 2003;70(2):67-74.
5. Houwerzijl EJ, Blom NR, van der Want JJ, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103(2):500-506.
6. Houwerzijl EJ, Blom NR, van der Want JJ, Vellenga E, de Wolf JT. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia. 2006;20(11):1937-1942.
7. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103(4):1364-1369.
8. Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102(3):887-895.
9. Barsam SJ, Psaila B, Forestier M, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011;117(21):5723-5732.
10. Gernsheimer T, Stratton J, Ballem PJ, Slichter SJ. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med. 1989;320(15):974-980.
11. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest. 1987;80(1):33-40.
12. Bussel JB, Buchanan GR, Nugent DJ, et al. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 2011;118(1):28-36.
13. Liu ZJ, Italiano J Jr, Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood. 2011;117(15):4106-4117.
14. Yougbaré I, Lang S, Yang H, et al. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest. 2015;125(4):1545-1556.
15. Greinacher A, Fuerll B, Zinke H, et al. Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia. Blood. 2009;114(6):1250-1253.
16. Warwick RM, Vaughan J, Murray N, Lubenko A, Roberts I. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia. Br J Haematol. 1994;88(4):874-877.